The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEurocell Regulatory News (ECEL)

Share Price Information for Eurocell (ECEL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 137.00
Bid: 135.00
Ask: 139.00
Change: 0.00 (0.00%)
Spread: 4.00 (2.963%)
Open: 137.00
High: 137.00
Low: 137.00
Prev. Close: 137.00
ECEL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Trading Update

10 May 2019 07:00

RNS Number : 5862Y
Eurocell plc
10 May 2019
 

10 May 2019

 

EUROCELL PLC

(Symbol: ECEL)

 

AGM Trading Update

 

Eurocell provides an update on its trading performance for the first four months of 2019, in advance of our Annual General Meeting being held at 12 noon today.

 

Trading and Operational Performance

We are pleased to report that the good start we made in the first two months of the year has continued through March and April.

 

We have delivered a good sales performance, albeit against weaker 2018 comparatives after bad weather in the early part of last year.

In the Profiles division, growth includes strong contributions from both existing and new accounts, arising consistently from across our base of fabricators. In Building Plastics, growth reflects strong like-for-like sales, supported by better stock availability and our new management team driving improvements in operating standards.

 

As planned, with customer service levels now returned to normal, we are implementing selling price increases progressively across the business in H1 2019 to recover cost inflation.

 

Capital Investment and Stock Build Programmes

In March, we announced a substantial capex programme to build the capacity required for future growth, including additional co-extrusion and foam lines (increasing capacity by 30% and 15% respectively) and new tooling. This investment is on track, with all of the new equipment expected to be operational by the end of Q3 as planned.

 

The investment to expand the recycling capacity at our Ilkeston and Ecoplas plants is underway, with efforts focused on ensuring that we leverage the most appropriate technology at each site.

 

In addition, given the possibility for raw material supply interruption due to Brexit, as previously reported we have invested in a stock build programme, adding approximately £3 million to finished goods for key product lines in Q1, which provides a good level of protection.

 

Appointment of Chief Operating Officer

In line with our continued focus on improving operations, and to support future growth, we are delighted to announce the appointment of Mark Hemming to the position of Chief Operating Officer. Mark joins us from Amazon UK, where he is currently Regional Director for Customer Fulfilment. Prior to that, Mark has experience from leading manufacturing plants in the automotive sector. He will join the business over the summer and is an excellent addition to our operational management team. 

 

Outlook

Our focus for 2019 remains on completing the implementation of the capital investments, in order to improve manufacturing efficiency and recover margins back to target levels. We are in a strong financial position and remain confident in our ability to deliver profits for the year in line with expectations.

 

Notice of Results

We will announce our half year results for the six months ending 30 June 2019 on 1 August 2019.

 

 

~~~~~~~~~~~~~~~~~~~~~~~

 

 

Notes:

Eurocell plc is a market leading, vertically integrated UK manufacturer, recycler and distributor of innovative window, door and roofline PVC products.

 

 

Enquiries:

Eurocell plc

Mark Kelly, Chief Executive Officer

+44 (0) 1773 842 105

 

Michael Scott, Chief Financial Officer

+44 (0) 1773 842 140

 

Teneo Blue Rubicon

Ben Foster

+44 (0) 20 3603 5221

 

Camilla Cunningham

+44 (0) 20 3757 9235

 

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTALMPTMBBMBJL
Date   Source Headline
22nd Apr 20247:00 amRNSDirector/PDMR Shareholding
19th Apr 20247:00 amRNSPublication of 2023 Annual Report & Notice of AGM
19th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:01 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSDirector/PDMR Shareholding
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSDirector/PDMR Shareholding
26th Mar 20244:30 pmRNSHolding(s) in Company
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSInvestor Presentation
20th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSBlock listing Interim Review
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20247:00 amRNSTransaction in Own Shares
28th Feb 20247:00 amRNSTransaction in Own Shares
27th Feb 20247:00 amRNSTransaction in Own Shares
23rd Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20247:00 amRNSTransaction in Own Shares
21st Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 20247:00 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSTransaction in Own Shares
16th Feb 20247:00 amRNSTransaction in Own Shares
15th Feb 20246:00 pmRNSHolding(s) in Company
15th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 20247:00 amRNSTransaction in Own Shares
13th Feb 20247:00 amRNSDirector/PDMR Shareholding
13th Feb 20247:00 amRNSTransaction in Own Shares
8th Feb 20247:00 amRNSTransaction in Own Shares
7th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20247:00 amRNSTransaction in Own Shares
2nd Feb 20247:00 amRNSTransaction in Own Shares
1st Feb 20247:00 amRNSTransaction in Own Shares
1st Feb 20247:00 amRNSNon-executive Directors' Share Purchase Plan

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.